Abstract
Magnesium sulfate has been considered a versatile anesthetic adjunct in the past, though its analgesic potential remains controversial. The discovery of its ability to block the N-methyl-D-aspartate receptor in the central nervous system has generated increasing interest in its use as a multimodal analgesic adjunct. Detrimental opioid-related side effects, as well a growing concern for opioid misuse, has heightened the desire to discover and use alternative agents for pain control. Many current Enhanced Recovery After Surgery (ERAS) protocols include intravenous (IV) magnesium sulfate as a component of the opioid-sparing anesthetic plan. In the featured case report, a 46-year-old morbidly obese female (BMI 42 kg/m2) presented for a robotic gastric sleeve for weight loss. This patient was at an increased risk for opioid-related adverse effects due to a history of obstructive sleep apnea and class III morbid obesity. As part of the facility’s ERAS protocol, the patient received celecoxib, acetaminophen, gabapentin, lidocaine, magnesium, fentanyl, ketamine, and ketorolac. Magnesium sulfate was given as a 2 g IV bolus after induction and prior to surgical incision. Throughout the maintenance phase, hemodynamic stability was maintained with 2 lactated ringers 250 mL boluses and 5 phenylephrine 100 mcg boluses for periods of hypotension. Vital signs were stable in the post-anesthesia care unit (PACU) with nonlabored spontaneous respirations and no dysrhythmias or ectopy. The patient was arousable and able to follow commands. When reassessed 45 minutes after PACU arrival, the patient was awake, alert, and resting comfortably. The patient had been weaned to room air and the SpO2 was 97%. The patient complained of occasional incisional pain with a numeric pain scale rating of 3/10 but did not request analgesics.
Sigma Membership
Non-member
Lead Author Affiliation
Samford University, Birmingham, Alabama, USA
Type
DNP Capstone Project
Format Type
Text-based Document
Study Design/Type
N/A
Research Approach
N/A
Keywords:
Magnesium Sulfate, Opioid-sparing, ERAS Protocol, Analgesia Adjunct
Advisor
Herbinger, Lisa
Second Advisor
Barnes, Lauren
Degree
DNP
Degree Grantor
Samford University
Degree Year
2021
Recommended Citation
Karst, Camille, "Magnesium sulfate effectiveness for ERAS Protocols" (2021). Group: Samford University Moffett & Sanders School of Nursing. 116.
https://www.sigmarepository.org/samford/116
Rights Holder
All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.
All permission requests should be directed accordingly and not to the Sigma Repository.
All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.
Review Type
None: Degree-based Submission
Acquisition
Proxy-submission
Date of Issue
2021-03-24
Full Text of Presentation
wf_yes